Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2014
09/02/2014US8822651 Human rhinovirus (HRV) antibodies
09/02/2014US8822650 Method for the mass production of immunoglobulin constant region
09/02/2014US8822649 Anti-CLTA4, anti-GLUT2 protein for the treatment of type 1 diabetes
09/02/2014US8822648 Antibody derivatives
09/02/2014US8822647 Method and compositions using a chimeric antigen receptor for enhanced anti-tumor effector functioning of T cells
09/02/2014US8822646 Cancer therapies and pharmaceutical compositions used therein
09/02/2014US8822645 Prostaglandin E2 dual variable domain immunoglobulins and uses thereof
09/02/2014US8822644 Method of treating cancer comprising a VEGF-B antagonist
09/02/2014US8822442 Somatostatin-dopamine chimeric analogs
09/02/2014US8822213 Bispecific intracellular delivery vehicles
09/02/2014US8822196 Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer
09/02/2014US8822169 HMG1 antibody for treating inflammatory conditions
09/02/2014US8822168 Assays for detecting small nuclear ribonucleoprotein particle assembly and survival of motor neurons activity
09/02/2014US8821890 Influenza virus vaccine composition and methods of use
09/02/2014US8821885 Immunogenic compositions and methods
09/02/2014US8821883 Method of treating B cell cancers by administering truncated BAFF receptors
09/02/2014US8821877 Methods for inhibiting HIV-1 replication involving the administration of an anti-CCR5 receptor monoclonal antibody and small molecule CCR5 receptor antagonist
09/02/2014US8821875 Pharmaceutical composition comprising antibodies against catalase and superoxide dismutase for tumor therapy
09/02/2014US8821874 KLK-13 antibody inhibitor for treating dry eye
09/02/2014US8821873 Treatment of diffuse large-cell lymphoma with anti-CD20 antibody
09/02/2014US8821872 Identification and characterization of a specific CCK-C receptor antibody for human pancreatic cancer and its use for early detection and staging of pancreatic cancer
09/02/2014US8821871 Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compounds and methods of use thereof
09/02/2014US8821870 Method for treating atrophic age related macular degeneration
09/02/2014US8821869 Treatment methods using c-Met antibodies
09/02/2014US8821867 4-1BB binding molecules
09/02/2014US8821866 Methods of treating and preventing colitis involving IL-13 and NK-T cells
09/02/2014US8821865 High concentration anti-TNFα antibody liquid formulations
09/02/2014US8821863 Humanized anti-α 9 integrin antibodies and the uses thereof
09/02/2014US8821856 Method of targeted gene delivery using viral vectors
09/02/2014CA2736974C Tumour-associated peptides that bind to mhc molecules
09/02/2014CA2594918C Dr5 antibodies and uses thereof
09/02/2014CA2438315C Attenuated pasteurellaceae bacteria and an anti-bacterial vaccine prepared therefrom
09/02/2014CA2413866C Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations
08/2014
08/28/2014WO2014130965A1 Gastrokine-1 (gkn1) binding proteins and methods of treatment
08/28/2014WO2014130657A1 Treatment of cancer using humanized anti-egfrviii chimeric antigen receptor
08/28/2014WO2014130635A1 Effective targeting of primary human leukemia using anti-cd123 chimeric antigen receptor engineered t cells
08/28/2014WO2014128628A1 Cytoplasmic expression of fab proteins
08/28/2014WO2014128259A1 Pharmaceutical composition for the treatment of burnout syndrome
08/28/2014WO2014128245A1 Dna hypomethylating agents for cancer therapy
08/28/2014WO2014128221A1 A compound that specifically binds to kir3dl2 for use in the treatment of peripheral t cell lymphoma
08/28/2014WO2014128185A1 Recombinant bispecific antibody that binds to the cd133 antigen on tumor cells and to the human cd3 t cell receptor
08/28/2014WO2014128168A1 Anti-cd26 antibodies and uses thereof
08/28/2014WO2014127917A1 Combination of vaccination and inhibition of the pd-1 pathway
08/28/2014WO2014127906A1 Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
08/28/2014WO2014127811A1 Acceptor framework for cdr grafting
08/28/2014WO2014127785A1 Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
08/28/2014WO2014106004A3 High-throughput system and method for identifying antibodies having specific antigen binding activities
08/28/2014WO2014106001A3 Dual specific binding proteins having a receptor sequence
08/28/2014WO2014102103A3 Heterologous intron within a signal peptide
08/28/2014WO2014089335A3 Bcma antigen binding proteins
08/28/2014WO2014071344A3 Method of isolating synagis® in the absence of benzonase
08/28/2014WO2012057877A3 Combinations of anti-s1p antibodies and sphingolipid pathway inhibitors
08/28/2014US20140245468 Non-human animals with modified immunoglobulin heavy chain sequences
08/28/2014US20140243509 Near infrared fluorogen and fluorescent activating proteins for in vivo imaging and live-cell biosensing
08/28/2014US20140243508 Method for the purification of antibodies
08/28/2014US20140243507 Method of screening antibodies with high antigen selectivity
08/28/2014US20140243506 Antagonists of il17c for the treatment of inflammatory disorders
08/28/2014US20140243505 Bispecific antibody
08/28/2014US20140243504 Antibodies comprising chimeric constant domains
08/28/2014US20140243503 Fgf21 mutants and uses thereof
08/28/2014US20140243502 Anticoagulation agent and uses thereof
08/28/2014US20140243265 Antibodies to modified human igf-1/e peptides
08/28/2014US20140243234 Nucleic acid compositions, methods and kits for rapid pairing of affinity agents
08/28/2014US20140242701 Chimeric antigen receptor
08/28/2014US20140242637 Artificial introns
08/28/2014US20140242636 Regulatable promoter
08/28/2014US20140242607 Antibody for detecting epithelial ovarian cancer marker and method for diagnosing epithelial ovarian cancer
08/28/2014US20140242106 Staphylococcus aureus proteins and nucleic acids
08/28/2014US20140242095 Antibodies and antibody fragments targeting sirp-alpha and their use in treating hematologic cancers
08/28/2014US20140242094 Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells
08/28/2014US20140242093 Methods and compositions for modulating the innate immune response and/or myogenesis in a mammalian subject
08/28/2014US20140242092 Vhz for diagnosis and treatment of cancer
08/28/2014US20140242091 Method for treating pathologies associated with hypoxia using mif inhibitors
08/28/2014US20140242090 Methods for the treatment of il-1beta related conditions
08/28/2014US20140242089 Glycoproteins having lipid mobilising properties and therapeutic applications thereof
08/28/2014US20140242086 Polynucleotides encoding signal peptide-containing molecules
08/28/2014US20140242085 Methods and composition for testing, preventing, and treating aspergillus fumigatus infection
08/28/2014US20140242084 Angiopoietin-Like 4 and Its Use in Modulating Cell Leakiness
08/28/2014US20140242083 Anti-mcsp antibodies
08/28/2014US20140242081 Dosing regimens for treatment of cea-expressing cancers
08/28/2014US20140242080 Bispecific t cell activating antigen binding molecules
08/28/2014US20140242079 Bispecific t cell activating antigen binding molecules
08/28/2014US20140242078 Methods and monitoring of treatment with a wnt pathway inhibitor
08/28/2014US20140242077 Methods and compositions for modulating an immune response
08/28/2014US20140242076 Multispecific mutated antibody fab fragments
08/28/2014US20140242075 Antibody variants and uses thereof
08/28/2014US20140242074 Materials and methods for modulating activity of bone marrow derived cells
08/28/2014US20140242073 Cartilage/bone destruction suppressor
08/28/2014US20140242072 Anti-icam-1 antibodies to treat multiple-myeloma related disorders
08/28/2014US20140242071 M-csf specific monoclonal antibody and uses thereof
08/28/2014US20140242070 Frizzled 2 as a target for therapeutic antibodies in the treatment of cancer
08/28/2014US20140242068 Jaml specific binding agents, antibodies, and uses related thereto
08/28/2014US20140242067 Treatment of central nervous system disorders by intranasal administration of immunoglobulin g
08/28/2014US20140242025 Multimeric il-15 soluble fusion molecules and methods of making and using same
08/28/2014US20140241988 Methods and compositions for treating atrial fibrillation
08/28/2014US20140241987 Alpha-synuclein antibodies and uses thereof
08/28/2014US20140241984 Alpha-synuclein antibodies and uses thereof
08/27/2014EP2770055A1 Nucleic acid derived from hepatitis C virus, and expression vector, transformed cell and hepatitis C virus particles each prepared by using the same
08/27/2014EP2769994A2 Ritalinic acid immunoassay
08/27/2014EP2769993A1 Antibodies against human NKG2D and uses thereof
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 1494